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Background: Fructus mume (F. mume) has been used as a traditional medicine for many years in Asian countries.
The present study was designed to determine the effect of a 70% ethanol extract of F. mume on white matter and
hippocampal damage induced by chronic cerebral hypoperfusion.
Methods: Permanent bilateral common carotid artery occlusion (BCCAo) was performed on male Wistar rats to induce
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continued for 42 days. The experimental groups in this study were divided into three groups: a sham-operated group, a
BCCAo group, and a BCCAo group that was administered with the F. mume extract. The activation of glial cells, including
microglia and astrocytes, and the levels of myelin basic protein (MBP), inflammatory mediators, Toll-like receptor 4 (TLR4),
myeloid differentiation factor 88 (MyD88), and p38 mitogen-activated protein kinase (MAPK) phosphorylation were
measured in brains from rats subjected to chronic BCCAo.
Results: Our results revealed that F. mume alleviates the reduction in MBP expression caused by chronic BCCAo in
the white matter and the hippocampus and significantly attenuates microglial and astrocytic activation induced
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of cyclooxygenase-2 (COX-2), interleukin-1β (IL-1β) and interleukin-6 (IL-6), as well as the activation of TLR4/MyD88 and
p38 MAPK signaling, in the hippocampus of rats subjected to chronic BCCAo.
Conclusion: Taken together, our findings demonstrate that brain injury induced by chronic BCCAo is ameliorated by the
anti-inflammatory effects of F. mume via inhibition of MBP degradation, microglial and astrocytic activation, increased
inflammatory mediator expression, and activated intracellular signalings, including TLR4 and p38 MAPK, implying that
F. mume is potentially an effective therapeutics for the treatment of vascular dementia.
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Cerebral blood flow (CBF) is tightly regulated by local
brain metabolism [1]. Nevertheless, several vascular risk
factors alter this homeostasis, consequently leading to the
decrease in CBF. A long-lasting reduction in CBF, defined
as chronic cerebral hypoperfusion, causes neurologic dys-
functions, including cognitive impairment and neuronal
damage [2], and it is involved in the development of de-
mentia such as Alzheimer’s disease (AD) and vascular de-
mentia (VaD) [3-5]. The rat model of permanent bilateral
common carotid artery occlusion (BCCAo) is widely used
to examine mild chronic cerebral hypoperfusion [5,6].
BCCAo immediately decreases CBF after occlusion and
maintains a persistent reduction in CBF for several months
[7]. This reduction in CBF of rats subjected to BCCAo ex-
hibits regional differences in various brain structures. For
example, CBF decreased by 35-45% of the normal level in
the cortex and the white matter and declined by 60% of
the normal level in the hippocampus of BCCAo-induced
rats [5]. Experimental evidences have demonstrated that
chronic cerebral hypoperfusion induced by BCCAo results
in damage to white matter regions, especially the corpus
callosum and the optic tract, because these regions are
more vulnerable to persistent obstruction of the blood sup-
ply from the carotid artery [8-10].
Neuroinflammation has been known to be correlated
with the occurrence of white matter lesions induced by
chronic cerebral hypoperfusion [11]. The inflammatory re-
sponse leads to activation of resident glial cells, such as
microglia and astrocytes, and upregulation of inflamma-
tory cytokines, such as tumor necrosis factor-α (TNF-α)
and interleukin-1β (IL-1β), aggravates the inflammation
after chronic cerebral hypoperfusion [12]. Fructus mume
(F. mume), the processed unripe fruit of Prunus mume,
has been utilized for the treatment of gastrointestinal dis-
eases in Asian countries for thousands of years. Several re-
ports have demonstrated that F. mume is useful for the
treatment of colitis in an inflammatory bowel disease
model [13] and attenuates lipopolysaccharide-induced in-
flammation in RAW 264.7 cells by inhibiting the produc-
tion of nitric oxide, prostaglandin E2, cyclooxygenase-2
(COX-2), and interleukin-6 (IL-6) [14]. However, the pro-
tective effect and mechanism of action of F. mume have
not yet been fully investigated in various pathological con-
ditions. Therefore, the aim of this study was to evaluate
the effect of F. mume on the white matter and hippocam-
pal damage in chronic cerebral hypoperfused rat and the




Fifty-five male Wistar rats were used in the chronic BCCAo
experiment (12 weeks old; Charles River Co., Gapyung,South Korea). For 2 weeks at the beginning of the experi-
ment, the rats were housed in a vivarium at the Korea In-
stitute of Oriental Medicine (KIOM) under controlled
temperature (22 ± 1°C) and humidity (55 ± 10%) with a
12 h light/dark cycle (lights on at 08:00 h). Food and water
were given ad libitum to all rats throughout the experi-
ment. All experimental procedures described in this report
were approved by the Institutional Animal Care and Use
Committee of the KIOM.Surgery
The Wistar rats were anesthetized with 5% isoflurane in a
mixture of 30% oxygen/70% nitrogen. Anesthesia was
maintained with 3% isoflurane using a face mask during
the surgical procedure. A midline incision was performed
to expose both common carotid arteries, which were then
tightly double-ligated using silk sutures. In addition, con-
trol rats were subjected to a sham operation in which they
underwent the same procedure without BCCAo. Rectal
temperature was maintained at 37.0 ± 0.5°C using a heating
pad throughout the surgical procedure. After permanent
BCCAo, two rats displayed neurological complications,
such as seizures with squatting, and these rats died within
one week after BCCAo surgery. In addition, three rats
whose weight decreased to 20% of their weight prior to the
surgery during drug or vehicle administration were ex-
cluded from this study.Preparation and administration of F. Mume extract
F. mume, produced in China, was obtained from a com-
mercial supplier (Kwangmyung-Dang, Ulsan, Korea) in
2012. It was identified by the Herbal Quality Control Team
and deposited at the Creative Research Laboratory of the
KIOM. Dried F. mume was pulverized and extracted in
70% ethanol (EtOH) for 3 h at room temperature using an
ultrasound-assisted extractor (OM30-EP; Sonimedi, Korea).
The extract was concentrated under a vacuum using a ro-
tary evaporator after filtration. The Wistar rats used in the
present study were segregated into three groups: a sham-
operated group that was orally administered the drug
vehicle daily (n = 16); a BCCAo group that was orally ad-
ministered the drug vehicle daily (n = 18); and a BCCAo
group that was orally administered the F. mume extract
200 mg/kg once a day (n = 20). Vehicle or drug treatment
was initiated on the 21th day after BCCAo or sham surgery
and was continued until the 41st day after first vehicle/drug
treatment by employing the oral gavage method. During
oral administration, two rats were lost from F. mume ex-
tract treatment group due to the stress related to long-term
oral feeding, but the F. mume extract displayed no toxicity
with respect to changes in general behavior and mortality.
The present study used normal saline as the vehicle.
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of the F. Mume extract
HPLC was accomplished using a Waters Alliance e2695
HPLC system with a 2996 PDA detector and a YMC
Hydrosphere C-18 column (5 mm, 4.6 × 250 mm i.d.)
(YMC Co. Ltd., Tokyo, Japan). The mobile phase was
comprised of acetonitrile (A) and water (B) using a step-
wise gradient elution mixture: (A)/(B) = 0/100 (0 min),
(A)/(B) = 10/90 (15 min), and (A)/(B) = 100/0 (40 min;
hold for 10 min). The flow rate was 1.0 ml/min. The crude
70% EtOH extract of F. mume was filtered by membrane
filters with a pore size 0.45 mm (Millipore), and the injec-
tion volume was 10 μl.
Western blot analysis
After the administration of F. mume extract or vehicle
was completed, all Wistar rats were decapitated, and
their brains were micro dissected and then frozen. Pro-
tein samples of the hippocampal tissue were extracted in
the following manner. Individual tissue samples were
weighed and then homogenized in five volumes of ice-
cold RIPA buffer containing 25 mM Tris HCl pH 7.6,
150 mM NaCl, 1% NP-40, 1% sodium deoxycholate,
0.1% SDS (Thermo Scientific, Waltham, MA, USA), pro-
tease inhibitor cocktail solution and phosphatase inhibi-
tor cocktail solution (GenDEPOT, Barker, TX, USA).
The homogenates were then centrifuged at 20,800 × g
for 1 h at 4°C, and the supernatants were harvested,
snap-frozen, and stored at −80°C. The protein concen-
tration of the supernatants was determined using the
BCA assay (Thermo Scientific, Waltham, MA, USA).
Equal amounts of protein (40 μg) were then separated
via SDS-PAGE and transferred to a PVDF membrane,
which was subsequently incubated in a primary antibody
(Ab) against COX-2 (Santa Cruz Biotechnologies, CA,
USA), IL-1β (Millipore Corporation, MA, USA), IL-6
(Abcam, CA, USA), Toll-like receptor 4 (TLR4), myeloid
differentiation factor 88 (MyD88, Santa Cruz Biotech-
nologies, CA, USA), phospho-p38 mitogen-activated
protein kinase (MAPK), p38 MAPK (Cell Signaling, MA,
USA), or glyceraldehyde-3-phosphate dehydrogenase
(GAPDH, Santa Cruz Biotechnologies, CA, USA). Follow-
ing incubation in the primary Ab, the membranes were in-
cubated in horseradish peroxidase (HRP)-conjugated
secondary Ab (Cell Signaling, MA, USA) and then de-
tected using an ECL system (Thermo Scientific, MA,
USA) with a Lumino Image Analyzer (Las-4000; Fujifilm,
Tokyo, Japan). Densitometry was performed for specific
markers normalized to GAPDH using Image J (v1.37)
software.
Immunohistochemistry
After the final administration of the F. mume extract or
vehicle, all rats were euthanized using lethal overdose ofZoletil (50 mg/kg) and Rompun (5 mg/kg), followed by in-
tracardial perfusion with 4% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4). Following fixation, the brains
were removed, post-fixed, treated with distilled water con-
taining 30% sucrose for cryoprotection, snap-frozen, and
sectioned (coronal plane: 40-μm) using a microtome. Next,
the sections were blocked overnight at 4°C using 1% casein
in phosphate buffered saline (PBS) containing 0.3% Triton-
X 100. Then, the sections were incubated in antibody
against NeuN (Millipore Corporation, MA, USA), myelin
basic protein (MBP, Abcam, CA, USA), ionized calcium
binding adaptor molecule-1 (Iba-1, Wako, Tokyo, Japan),
or glial fibrillary acidic protein (GFAP, Abcam, CA, USA)
for 1 h at room temperature. The sections were washed
with PBS three times for 10 min each and then incubated
in the appropriate biotinylated secondary antibodies
(Thermo Scientific, MA, USA) for 2 h. Subsequently, the
sections were incubated in the ExtrAvidin peroxidase con-
jugate (Sigma Aldrich, MO, USA) for 1 h. Finally, the
stained sections were treated with a Vector SG substrate
kit and a Vector DAB kit (Vector Laboratories, CA, USA)
for peroxidase-mediated staining. Sections were then
mounted onto resin-coated slides and dried for up to
1 week. They were finally coverslipped using permount
reagent and images were taken at magnifications of 40× or
200× with an electron microscope (Olympus, Tokyo,
Japan).
To quantify glial cells, the number of Iba-1- or GFAP-
positive cells was counted. For a quantitative analysis, we
selected specific regions reported to show neuroinflamma-
tory changes [15]. Sections including the corpus callosum,
fimbria, optic tract, and hippocampus from 7–9 rats per
group were analyzed and Iba-1- and GFAP-positive cells
were counted in ROIs of 0.03 mm2 in each region using
the image J (v1.37) software. In addition, the optical dens-
ity of MBP staining was measured in ROIs of 0.03 mm2 in
each region using the Metamorph analysis software (Mo-
lecular devices, CA, USA). The observed number of Iba-
1- and GFAP-positive cells, as well as the optical density
of MBP staining in each ROI was averaged.Statistical analysis
One-way ANOVAs were performed to determine the ef-
fects of F. mume administration on alterations in the
number of MBP, NeuN, GFAP, and Iba-1-positive cells,
as well as the expression levels of COX-2, IL-1β, IL-6,
TLR4, MyD88, and p38 MAPK induced by chronic
BCCAo. Tukey’s post-hoc analyses were subsequently
performed to determine the significance of the effects of
F. mume treatment in chronic BCCAo rats. Unless
otherwise specified, p values less than 0.05 were consid-
ered to be significant. All data are expressed as the
mean ± SEM.
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HPLC analysis of 70% EtOH extract of F. mume
As shown in Additional file 1: Figure S1, the 70% EtOH ex-
tract of F. mume contained benzyl-O-β-D-glucopyranoside
(1), benzyl-O-α-L-arabinopyranosyl-β-D-glucopyranoside
(2), benzyl-O-β-D-xylopyranosyl-β-D-glucopyranoside (3),
prunasin (4), α-hydroxy-benzeneacetamide (5), and 5-
hydroxymethyl-2-furaldehyde (6).
F. mume restored the MBP expression reduced by chronic
cerebral hypoperfusion
The white matter is principally composed of myelin and
nerve fibers. The degradation of myelin, an insulating
layer that forms the myelin sheath, is a causative factor in
white matter damage induced by chronic cerebral hypo-
perfusion, and MBP plays an important role in myelin-
ation as a component in the myelin sheath [16]. We
investigated the effects of F. mume on chronic BCCAo-
induced MBP breakdown in the medial septum, corpus
callosum, and fimbria of the white matter and the hippo-
campus. ANOVA analysis revealed significant group ef-
fects of MBP expression in the medial septum, corpusFigure 1 Effect of F. mume on MBP expression in the white matter and the h
expression level of MBP in the white matter regions and the hippocampus in t
the BCCAo + F. mume group (n = 9). (A) Representative photomicrograph of M
corpus callosum, the fimbria of the white matter, and the hippocampus of BCC
via ANOVA followed by the Tukey test.*, p < 0.05 versus the BCCAo+ Vehicle g
fimbria; HC, hippocampus; CC, corpus callosum.callosum, and fimbria of the white matter and the hippo-
campus between sham-operated controls, BCCAo rats
treated with vehicle, and BCCAo rats treated with F. mume
(F(2,23) ≥ 5.94, p < 0.01). Post-hoc analyses revealed that
compared to the sham-operated controls, the expression
level of MBP in the BCCAo rats treated with vehicle was
apparently decreased in the medial septum, corpus callo-
sum, and fimbria of the white matter and the hippocampus
(Figure 1A and B). F. mume restored the level of MBP ex-
pression that was reduced by BCCAo in these regions, but
these effects of F. mume were not statistically significant.
F. mume attenuated microglial and astrocytic activation
induced by chronic cerebral hypoperfusion
Glial cells, such as astrocytes and microglia, play a cen-
tral role in neuroinflammation, and activation of these
cells is detected in the brain of animals subjected to
chronic cerebral hypoperfusion [17,18]. To investigate
whether F. mume affects microglial and astrocytic activa-
tion in the white matter and the hippocampus of rats
subjected to BCCAo, Iba-1 and GFAP are used as activa-
tion markers of microglia and astrocytes, respectivelyippocampus.. Immunohistological staining was performed to evaluate the
he sham-operated group (n = 8), the BCCAo + Vehicle group (n = 9), and
BP-positive cells. (B) MBP level was decreased in the medial septum, the
Ao-injured rats compared to sham-operated rats (*). Data were analyzed
roup. LV, lateral ventricle; MS, medial septum; CC, corpus callosum; FI,
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in the corpus callosum (Iba-1, F(2,23) = 3.84, p = 3.64e-
02; GFAP, F(2,23) = 6.27, p = 2.40e-03), the fimbria
(GFAP, F(2,22) = 7.47, p = 9.18e-04), and the optic tract
(Iba-1, F(2,22) = 28.92, p = 6.95e-07; GFAP, F(2,22) =
26.7, p = 4.12e-08) of the white matter, and the CA1
(Iba-1, F(2,22) = 7.79, p = 2.78e-03; GFAP, F(2,22) = 8.50,
p = 4.22e-04) of the hippocampus between sham-operated
controls, BCCAo rats treated with vehicle, and BCCAo
rats treated with F. mume (Figures 2 and 3). Post-hoc ana-
lyses indicated that compared to the sham-operated con-
trols, the number of Iba-1-positive cells in the optic tract
and the CA1 of the vehicle-treated BCCAo rats was re-
markably increased (Figure 2B and D), and the number of
GFAP-positive cells was also raised in the corpus callo-
sum, the fimbria, the optic tract and the CA1 (Figure 3
from B to D). In addition, F. mume treatment significantly
inhibited the increase in Iba-1-positive cells in the optic
tract and in GFAP-positive cells in the corpus callosum,
the fimbria, the optic tract and the CA1 compared to
BCCAo rats treated with vehicle. In addition, the neuronal
cell death induced by chronic BCCAo is reduced in the
hippocampus of BCCAo rats treated with F. mume.Figure 2 Effects of F. mume on chronic BCCAo-induced microglial activation
investigate the expression of Iba-1-positive cells in the white matter and the h
group (n = 9), and the BCCAo + F. mume group (n = 9). Representative photo
cells was increased in the cerebral cortex, fimbria, the optic tract and CA1 of t
significantly decreased in the optic tract of the BCCAo rats treated with F. mu
ANOVA followed by the Tukey test. *, p < 0.05 versus the BCCAo + Vehicle
cornuammonis 1 and 3; DG, dentate gyrus.However, this finding did not show statistical significance
(Additional file 2: Figure S2).
F. mume alleviated the increased expression of
inflammatory mediators induced by chronic cerebral
hypoperfusion
The inflammatory response has been hypothesized to
cause the white matter and the hippocampal damage
after chronic cerebral hypoperfusion [20]. Proinflamma-
tory cytokines are released from activated microglia and
astrocytes, which subsequently contributes to neuronal
injury [21,22]. In the present study, we investigated the
hippocampal level of COX-2, IL-1β, and IL-6 to deter-
mine the effect of F. mume treatment in chronic BCCAo
rats. ANOVA analysis revealed significant group effects
of the hippocampal level of COX-2, IL-1β, and IL-6
(F(2,23) ≥ 8.16, p < 0.01) between sham-operated controls,
BCCAo rats treated with vehicle, and BCCAo rats treated
with F. mume. Post-hoc analyses of the group effects indi-
cated that chronic BCCAo rats exhibited the increase of
COX-2, IL-1β, and IL-6 expression in the hippocampus
(Figure 4A through D) compared to sham-operated control
rats. The increased expression of these proinflammatoryin the white matter. Immunohistological staining was conducted to
ippocampus in the sham-operated group (n = 7-8), the BCCAo + Vehicle
micrograph of Iba-1- (A and B). The number of Iba-1- (C and D) positive
he BCCAo-injured rats compared to the sham-operated rats (*), and was
me compared to the BCCAo-injured rats (#). Data were analyzed via
group; #, p < 0.05 versus the BCCAo + F. mume group. CA 1 and 3,
Figure 3 Effects of F. mume on chronic BCCAo-induced astrocytic activation in the white matter. Immunohistological staining was conducted to
investigate the expression of GFAP-positive cells in the white matter and the hippocampus in the sham-operated group (n = 7-8), the BCCAo + Vehicle
group (n = 9), and the BCCAo+ F. mume group (n = 9). Representative photomicrograph of GFAP (A and B) positive cells. The number of GFAP (C and
D)-positive cells was increased in the cerebral cortex, fimbria, the optic tract and CA1 of the BCCAo-injured rats compared to the sham-operated rats (*),
and was significantly decreased in the optic tract of the BCCAo rats treated with F. mume compared to the BCCAo-injured rats (#). Data were analyzed via
ANOVA followed by the Tukey test. *, p < 0.05 versus the BCCAo + Vehicle group; #, p < 0.05 versus the BCCAo + F. mume group. CA 1 and 3,
cornuammonis 1 and 3; DG, dentate gyrus.
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decreased in chronic BCCAo rats treated with F. mume
(Figure 4A through D).
F. mume downregulated TLR4 and p38 MAPK signaling in
the hippocampus
TLR4 signaling is involved in both glial cell activation
and upregulation of proinflammatory cytokines [23-25].
To explore the effect of F. mume on TLR4 signaling in
chronic BCCAo rats, we measured the hippocampal
level of TLR4 and MyD88. ANOVA analysis of TLR4
and MyD88 expression revealed significant group ef-
fects in the hippocampus between sham operated con-
trols, BCCAo rats treated with vehicle, and BCCAo rats
treated with F. mume (F(2,23) ≥ 6.52, p < 0.01). Subse-
quent post-hoc analyses revealed that the expression
level of TLR4 and MyD88 was increased in the hippo-
campus of chronic BCCAo rats treated withvehicle
compared to sham-operated rats (Figure 5A and B). The
increased hippocampal level of TLR4 and MyD88 in-
duced by chronic BCCAo was not observed in BCCAo
rats treated with F. mume (Figure 5A). MAPK signaling
is associated with the production of proinflammatory
mediators in microglia and astrocytes [20] and isactivated in the brains of rats subjected to chronic
BCCAo [26-29]. We examined the correlation between
F. mume treatment and p38 MAPK phosphorylation in
the hippocampus in rats subjected to chronic BCCAo.
ANOVA analysis of p38 MAPK phosphorylation re-
vealed significant group effects in the hippocampus
(F(2,23) = 19.93, p = 9.52e-06). Subsequent post-hoc
analyses indicated that the level of p38 MAPK phos-
phorylation was increased in the hippocampus of
chronic BCCAo rats treated with vehicle compared to
sham-operated rats (Figure 5B). The increase in the
hippocampal level of p38 MAPK phosphorylation in-
duced by chronic BCCAo was significantly reduced in
chronic BCCAo rats treated with F. mume (Figure 5B).
These findings suggest that the anti-inflammatory ef-
fects of F. mume might be mediated via inhibition of
the activation of TLR4 and p38 MAPK signaling in re-
sponse to chronic cerebral hypoperfusion.
Discussion
In a previous study, we demonstrated that F. mume ex-
tracted using hot water mitigates the spatial memory
impairments induced by chronic BCCAo via the restor-
ation of abnormal microglial activation and altered
Figure 4 Effects of F. mume on hippocampal expression level of inflammatory mediators in chronic BCCAo rats. (A) Representative western blots of
COX-2, IL-1β, and IL-6. Densitometry was performed for COX-2, IL-1β, and IL-6 normalized to GAPDH using Image J (v1.37) software. (B through D)
The expression level of the inflammatory mediators (COX-2, IL-1β, and IL-6) was increased in the BCCAo + Vehicle group (n = 10) compared to the
sham-operated group (n = 8). Treatment with F. mume (n = 8) attenuated the increased level of the inflammatory mediators induced by chronic BCCAo
in the hippocampus (#). Data were analyzed via ANOVA followed by the Tukey test. *, p < 0.05 versus the BCCAo + Vehicle group; #, p <0.05 versus the
BCCAo + F. mume group.
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nuclear factor-κB (NF-κB) in the hippocampus [26]. Our
present study demonstrated a neuroprotective effect of F.
mume extracted using 70% EtOH on chronic cerebral
hypoperfusion-induced brain dysfunction through inhibit-
ing MBP degradation, activation of microglia and astro-
cytes, increased proinflammatory mediator expression, and
stimulation of TLR4 and p38 MAPK signaling. F. mume
has long been used as a traditional medicine in Asian con-
tries. The efficacy of F. mume has been known to include
anti-bacterial [30], anti-inflammatory [14], and anti-diabeticproperties [31]. According to HPLC analysis, the 70% EtOH
extract of F. mume had benzyl-O-β-D-glucopyranoside,
benzyl-O-α-L-arabinopyranosyl-β-D-glycopyranoside,
benzyl-O-β-D-xylopyranosyl-β-D-glycopyranoside, pruna-
sin, α-hydroxy-benzeneacetamide, and 5-hydroxymethyl-2-
furaldehyde (Additional file 1: Figure S1).
White matter, which is generally composed of glial cells
and myelinated axons, is vulnerable to chronic cerebral
hypoperfusion [32]. White matter lesions are detected in
the brains of AD and VaD patients with chronic cerebral
hypoperfusion as a result of glial cell activation and myelin
Figure 5 Effects of F. mume on the activation of TLR4 and p38 MAPK signaling. (A and B) Representative western blots of TLR4, MyD88, phospho-p38
MAPK, p38 MAPK, and GAPDH. Densitometry was performed for TLR4, MyD88, phospho-p38 MAPK, and p38 MAPK normalized to GAPDH using Image J
(v1.37) software. (A and B) The hippocampal levels of TLR4, MyD88, and phospho-p38 MAPK were increased in the BCCAo+ Vehicle group (n = 10) (*)
compared to the sham-operated group (n = 8). Treatment with F. mume (n = 8) decreased the hippocampal levels of TLR4, MyD88, and phospho-p38
MAPK increased by chronic BCCAo (#). Data were analyzed via ANOVA followed by the Tukey test. *, p < 0.05 versus the BCCAo+ Vehicle group; #, p <0.05
versus the BCCAo+ F. mume group.
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tween demyelination and inflammation in the injured brain
after hypoxia-ischemia, MBP expression and glial cell acti-
vation have been measured, since demyelination was ac-
companied with neuroinflammtion, such as activation of
glial cells and release of proinflammatory cytokines [33,34].
In the present study, MBP expression, a marker of mye-
lin sheath structure, was significantly decreased in the
white matter of rats subjected to chronic BCCAo, but this
reduction was alleviated by administration of F. mume.
This result indicates that F. mume can protect the brain
from chronic cerebral hypoperfusion-induced white mat-
ter lesions by restoring the decrease in MBP expression.
Inflammatory events play a crucial role in the pathogen-
esis of neurological diseases, including AD and VaD [35].
Chronic cerebral hypoperfusion-induced inflammation ischaracterized by activation of glial cells and overexpression
of inflammatory mediators, such as TNF-α and IL-1β
[8,11,36]. Therefore, inhibition of these inflammatory re-
sponses is important for protecting the brain injury in-
duced by chronic cerebral hypoperfusion. Microglia and
astrocytes are activated by various events, such as ischemia,
infection, and inflammation, which subsequently stimulate
the release of cytotoxic agents, including cytokines, matrix
metallo proteinases, nitric oxide, and reactive oxygen spe-
cies [12]. We found that F. mume significantly attenuates
microglial and astrocytic activation in the white matter and
hippocampus in rats subjected to chronic BCCAo. In
addition, treatment with F. mume alleviates the increase in
hippocampal COX-2, IL-1β, and IL-6 expression in chronic
BCCAo rats. Toll-like receptors (TLRs) play a pivotal role
in the initiation of innate immune responses. Among the
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cytes and participates in activation of these cells induced by
hypoxia in the brain [22,37,38]. Several studies have re-
ported that TLR4-dependent activation of microglia and as-
trocytes is involved in neurodegenerative diseases [35,38].
We have previously demonstrated that F. mume inhibits
the stimulation of IKK/NF-κB signaling induced by chronic
BCCAo in the rat hippocampus [26]. Moreover, the phos-
phorylation of MAPK-related signaling molecules, such as
ERKs, c-Jun amino-terminal kinases (JNKs), and p38
MAPK, is important for the production of proinflammatory
mediators, including TNF-α, IL-1β, and IL-6, in microglia
and astrocytes [20,28]. It has been reported that specific in-
hibition of p38 MAPK using SB203580 attenuated the in-
crease in expression of TNF-α, IL-1β, and IL-6 in the
hippocampus activated by mitogenic factor-induced inflam-
mation [39]. In the present study, we demonstrated that ac-
tivation of TLR4/MyD88 signaling and p38 MAPK
signaling is suppressed by treatment with F. mume in rats
subjected to chronic BCCAo.
Conclusion
The present study demonstrated that F. mume exerts an
anti-inflammatory effect by attenuating white matter le-
sions, microglial and astrocytic activation, the increased
expression of proinflammatory mediators, and the stimu-
lation of TLR4 and p38 MAPK signaling that are induced
by chronic cerebral hypoperfusion, suggesting a novel
mechanism to explain the anti-inflammatory action of F.
mume and its potential usefulness as a neuroprotective
agent for the treatment and prevention of neurodegenera-
tive diseases.
Additional files
Additional file 1: Figure S1. HPLC chromatogram of the 70% EtOH extract
ofF. mume. Benzyl-O-β-D-glucopyranoside (1), benzyl-O-α-L-arabinopyranosyl-
β-D-glucopyranoside (2), benzyl-O-β-D-xylopyranosyl-β-D-glucopyranoside
(3), prunasin (4), α-hydroxy-benzeneacetamide (5), and 5-hydroxymethyl-2-
furaldehyde (6).
Additional file 2: Figure S2. Effect of F. mumeon chronic BCCAo-induced
neuronal cell death in the hippocampus. Immunohistological staining was
performed to determine the number of NeuN-positive cells in CA1, CA3 and
DG regions of hippocampus in the sham-operated group (n=8), BCCAo+Vehicle
group (n = 9), and BCCAo + F. mume group (n = 9). (A) Representative
photomicrograph of NeuN-positive cells. To quantify neuronal cell death,
the number of NeuN positive cells was counted in CA1, CA3 and DG regions
of hippocampus. One region of interest (ROI) of 0.03 mm2 per one section
in CA1, CA3, and DG of hippocampus were selected. The number of NeuN
positive cells was counted in each ROI and averaged. (B) NeuN-positive cells
were reduced in CA1, CA3, and DG of the hippocampus in the chronic
BCCAo rats compared to sham-operated control rats. The reduction of
NeuN-positive cells induced by chronic BCCAo was not observed in
chronic BCCAo rats treated with F. mume. However, the statistical significance in
these results was not observed. CA 1 and 3, cornu ammonis 1 and 3; DG,
dentate gyrus.
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